Angiotensin 2 Receptor Blocker [EPC]

282877 reported adverse events

Drugs of this class: VALSARTAN AND HYDROCHLOROTHIAZIDE VALSARTAN IRBESARTAN TELMISARTAN IRBESARTAN AND HYDROCHLOROTHIAZIDE AMLODIPINE AND VALSARTAN TELMISARTAN AND HYDROCHLOROTHIAZIDE TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE AND VALSARTAN

These side effects are most commonly reported by patients taking drugs of the Angiotensin 2 Receptor Blocker [EPC] class:

#	Side effect	Count
0	DIZZINESS	16629
1	DYSPNOEA	16588
2	FATIGUE	16549
3	HYPOTENSION	14902
4	DEATH	12829
5	DRUG INEFFECTIVE	12400
6	COUGH	11784
7	NAUSEA	10677
8	MALAISE	10473
9	DIARRHOEA	9860

See all common reactions for Angiotensin 2 Receptor Blocker [EPC]

Drugs of the Angiotensin 2 Receptor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	THROAT CLEARING	1354	0.5262
1	NEUROLOGIC NEGLECT SYNDROME	158	0.4389
2	EJECTION FRACTION ABNORMAL	377	0.3831
3	CAROTID ARTERY THROMBOSIS	160	0.2614
4	BLOOD PRESSURE INADEQUATELY CONTROLLED	1401	0.2505
5	N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED	212	0.2294
6	CARDIAC FAILURE CHRONIC	699	0.2100
7	CARDIAC DYSFUNCTION	451	0.1980
8	EJECTION FRACTION DECREASED	2400	0.1886
9	ADJUSTMENT DISORDER	168	0.1673

See all enriched reactions for Angiotensin 2 Receptor Blocker [EPC]